| BIOMARIN PHAR. DL-,001 | 71,22 / -1,85% |
| 日期/時間 | 22.01. / 08:04 |
| 漲跌。 / 漲跌。(%) | -1,34 / -1,85% |
| Bid | - |
| Ask | - |
| 打開 | 71,22 |
| 過往收市 | 72,56 |
| 高 | 71,22 |
| 低 | 71,22 |
| 成交量 [EUR] | 0,00 |
| 成交量 [Units] | 0 |
| Price fixings | 1 |
| ISIN | US09061G1013 |
| 符號 | BM8 |
| 交易所 | München |
| 類型 | 股票 |
所有交易
| 交易所 | 最後的 | 成交量 | |
|---|---|---|---|
| Lang & Schwa.. | 71,73 |  |
|
| NASDAQ | 87,9900 |  |
898.579 |
| IEX | 88,01 | |
47.244 |
| Cboe US | 88,15 | |
28.240 |
| Mexico | 1.760,00 | |
662 |
| Vienna Globa.. | 72,06 | |
248 |
| TradeGate | 72,790 | |
149 |
| London Inter.. | 86,80 | |
127 |
| Frankfurt | 70,7600 |  |
17 |
| Stuttgart | 71,990 | |
10 |
| Xetra | 72,11 | |
0 |
| Berlin | 71,02 | |
0 |
| München | 71,22 | |
0 |
| Düsseldorf | 72,16 | |
0 |
| gettex | 72,370 | |
新聞
- BioMarin sinks 32% as FDA delays its hemophilia treatment
19.08.2020 / 16:23 - TeleTrader - Nasdaq turns red as pharma stocks fall
28.04.2020 / 16:48 - TeleTrader - BioMarin Enrolls First Participant in Phase 3 Trial of Vosoritide for Treatment of Children with Achondroplasia
12.12.2016 / 14:29 - GlobeNewswire - NICE Recommends BioMarin's Vimizim® (elosulfase alfa) for the Treatment of Morquio A Syndrome in England
23.11.2015 / 16:59 - GlobeNewswire